股票 › MDXG
美迈德生物 MDXG
美股市值排名 #3671
$3.31 +$0.03 (+0.91%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $3.31 0.00%
开盘$3.25
昨收$3.28
当日区间$3.23 – $3.39
成交量1.11M
市值$483.01M
市盈率（TTM）–
股息率–
财报
财报日平均波动±9.3%近16次财报
收涨次数10 / 1663% 的概率
最佳反应+39.4%
最差反应-13.0%
每次财报后次日股价变动
| 季度 | 财报日期 | 时段 | 隐含波动 | 实际波动 | 较隐含波动 |
|---|---|---|---|---|---|
| 2026/Q3 | 28 Oct 2026 | After Market | – | +0.51% | – |
| 2026/Q2 | 29 Jul 2026 | After Market | – | +0.95% | – |
| 2026/Q1 | 29 Apr 2026 | After Market | – | +8.91% | – |
| 2025/Q4 | 25 Feb 2026 | After Market | ±15.9% | -6.44% | 符合区间 |
| 2025/Q3 | 29 Oct 2025 | After Market | ±17.0% | +2.92% | 符合区间 |
| 2025/Q2 | 30 Jul 2025 | After Market | ±22.0% | +10.28% | 符合区间 |
| 2025/Q1 | 30 Apr 2025 | After Market | ±21.7% | -8.14% | 符合区间 |
| 2024/Q4 | 26 Feb 2025 | After Market | ±30.0% | +1.62% | 符合区间 |
| 2024/Q3 | 30 Oct 2024 | After Market | ±14.9% | +20.39% | 超出定价预期 |
| 2024/Q2 | 31 Jul 2024 | After Market | ±19.1% | -10.34% | 符合区间 |
| 2024/Q1 | 30 Apr 2024 | After Market | ±26.0% | +18.67% | 符合区间 |
| 2023/Q4 | 28 Feb 2024 | After Market | ±21.2% | -0.49% | 符合区间 |
| 2023/Q3 | 30 Oct 2023 | After Market | ±25.3% | +3.80% | 符合区间 |
| 2023/Q2 | 1 Aug 2023 | After Market | ±14.5% | -2.90% | 符合区间 |
| 2023/Q1 | 2 May 2023 | After Market | ±31.2% | +39.37% | 超出定价预期 |
| 2022/Q4 | 28 Feb 2023 | After Market | ±22.2% | -12.99% | 符合区间 |
"隐含波动"指财报发布前期权市场定价的预期波幅。"波动"指财报发布后首个交易日的股价变化。
营收构成
2026/Q2 季度
按业务线
基本面
最新报告季度：Q3, ended Sep 2026
营收$62.28M-45.2% YoY
营业利润-$11.70M-152.7% YoY
净利润-$8.68M-151.8% YoY
摊薄每股收益-$0.06-154.5% YoY
自由现金流-$1.14M-104.5% YoY
经营现金流$3.92M
营收，近8个季度
净利润，近8个季度
盈利能力与资产负债表
毛利率77.3%
营业利润率-8.3%
净利率-6.3%
净资产收益率-8.5%
资产收益率-6.6%
投入资本回报率-8.5%
流动比率4.35
负债/资产比率20.2%
现金及投资$120.79M
净现金（净负债）$120.79M
自由现金流/营收5.9%
暂无评论——快来第一个聊聊 MDXG。
登录后参与讨论。